Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
出版年份 2021 全文链接
标题
Acute immune signatures and their legacies in severe acute respiratory syndrome coronavirus-2 infected cancer patients
作者
关键词
-
出版物
CANCER CELL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-01-10
DOI
10.1016/j.ccell.2021.01.001
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- (2020) Barnaby Edward Young et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
- (2020) M.L. Solodky et al. ANNALS OF ONCOLOGY
- Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
- (2020) Philippe Guilpain et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry
- (2020) Milena Gianfrancesco et al. ANNALS OF THE RHEUMATIC DISEASES
- Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19
- (2020) Yang Yang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal
- (2020) Masumi Ueda et al. Journal of the National Comprehensive Cancer Network
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- A serological assay to detect SARS-CoV-2 seroconversion in humans
- (2020) Fatima Amanat et al. NATURE MEDICINE
- Temporal dynamics in viral shedding and transmissibility of COVID-19
- (2020) Xi He et al. NATURE MEDICINE
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing
- (2020) Wen Wen et al. Cell Discovery
- Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience
- (2020) Vallari Shah et al. BRITISH JOURNAL OF HAEMATOLOGY
- A minimal common outcome measure set for COVID-19 clinical research
- (2020) John C Marshall et al. LANCET INFECTIOUS DISEASES
- The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study
- (2020) Camille Maringe et al. LANCET ONCOLOGY
- Factors associated with COVID-19-related death using OpenSAFELY
- (2020) Elizabeth J. Williamson et al. NATURE
- Longitudinal analyses reveal immunological misfiring in severe COVID-19
- (2020) Carolina Lucas et al. NATURE
- Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
- (2020) Divij Mathew et al. SCIENCE
- Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
- (2020) Philip J. M. Brouwer et al. SCIENCE
- Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients.
- (2020) David J Pinato et al. Cancer Discovery
- Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London
- (2020) Beth Russell et al. Frontiers in Oncology
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- A dynamic COVID-19 immune signature includes associations with poor prognosis
- (2020) Adam G. Laing et al. NATURE MEDICINE
- Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settings
- (2020) Suzanne Pickering et al. PLoS Pathogens
- Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
- (2020) Jeffrey Seow et al. Nature Microbiology
- Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
- (2020) Abi Vijenthira et al. BLOOD
- Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer
- (2020) Victoria A. Avanzato et al. CELL
- Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
- (2020) Bina Choi et al. NEW ENGLAND JOURNAL OF MEDICINE
- CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
- (2019) Laura M. McLane et al. Annual Review of Immunology
- Molecular pathology of emerging coronavirus infections
- (2014) Lisa E Gralinski et al. JOURNAL OF PATHOLOGY
- Prolonged respiratory viral shedding in transplant patients
- (2013) C.R.A. de Lima et al. Transplant Infectious Disease
- Evaluation of 2009 pandemic H1N1 influenza vaccination in adults with lymphoid malignancies receiving chemotherapy or following autologous stem cell transplant
- (2012) Diego Villa et al. LEUKEMIA & LYMPHOMA
- NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections
- (2012) Raymond M. Welsh et al. VIROLOGY
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
- (2010) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- Evaluation of regression methods when immunological measurements are constrained by detection limits
- (2008) Hae-Won Uh et al. BMC IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started